drugset / Trial / NCT06597201

Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

NCT06597201 ↗

Phase 4 Recruiting 400 enrolled Chengdu Qingshan Likang Pharmaceutical Co., Ltd
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multicenter, randomized, parallel controlled Phase IV clinical study to evaluate the safety and efficacy of amino acid (15) peritoneal dialysis solution in patients undergoing peritoneal dialysis with malnutrition in CAPD patients undergoing peritoneal dialysis maintenance.

Timeline

Start
2024-08-09
Primary completion
2025-06-29
Completion
2025-06-29

Drugs

EvaluationDrugModalityDoseRoute
Subject amino acid (15) peritoneal dialysis solution Unknown 2000 ml Other
Comparator glucose peritoneal dialysis solution Unknown 2000 ml Other